硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
人 NTHL1 抗体对
试剂盒

人 NTHL1 抗体对

01AB04108

Endonuclease III-like protein 1 (NTHL1) is a DNA glycosylase that plays a critical role in the base excision repair (BER) pathway, specifically targeting oxidative DNA damage. It recognizes and removes damaged bases, particularly those caused by reactive oxygen species, thereby maintaining genomic stability. NTHL1 is essential for repairing apurinic/apyrimidinic sites in DNA, which are common lesions that can lead to mutations if left unrepaired. Dysregulation or mutations in the NTHL1 gene have been linked to various diseases, notably a novel predisposition syndrome for colorectal cancer characterized by biallelic inactivation of NTHL1, leading to impaired DNA repair mechanisms. Additionally, loss-of-function mutations in NTHL1 have been associated with increased susceptibility to other cancers due to the accumulation of DNA damage.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
NTHL1
基因别名
NTH1; OCTS3
蛋白别名
nth like DNA glycosylase 1; NTHL1
UniProt
P78549
物种
Human

产品详情

靶点名称
NTHL1
蛋白名称
nth like DNA glycosylase 1
蛋白别名
Endonuclease III-like protein 1; hNTH1; Bifunctional DNA N-glycosylase/DNA-(apurinic or apyrimidinic site) lyase; DNA glycosylase/AP lyase
靶点基因名
NTHL1
基因别名
NTH1; OCTS3
UniProt
P78549
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

Endonuclease III-like protein 1 (NTHL1) is a DNA glycosylase that plays a critical role in the base excision repair (BER) pathway, specifically targeting oxidative DNA damage. It recognizes and removes damaged bases, particularly those caused by reactive oxygen species, thereby maintaining genomic stability. NTHL1 is essential for repairing apurinic/apyrimidinic sites in DNA, which are common lesions that can lead to mutations if left unrepaired. Dysregulation or mutations in the NTHL1 gene have been linked to various diseases, notably a novel predisposition syndrome for colorectal cancer characterized by biallelic inactivation of NTHL1, leading to impaired DNA repair mechanisms. Additionally, loss-of-function mutations in NTHL1 have been associated with increased susceptibility to other cancers due to the accumulation of DNA damage.